Showing papers by "Stephen S Lim published in 2019"
TL;DR: The exposure to air pollution and its impact on deaths, disease burden, and life expectancy in every state of India in 2017 was estimated to inform action at subnational levels in India.
522 citations
Farin Kamangar, Dariush Nasrollahzadeh1, Saeid Safiri1, Sadaf G. Sepanlou +177 more•Institutions (1)
TL;DR: Although the overall colorectal cancer age-standardised death rate has been decreasing at the global level, the increasing age- standardised incidence rate in most countries poses a major public health challenge across the world.
421 citations
TL;DR: In this paper, the authors provide a comprehensive assessment of the levels and trends of HIV/AIDS incidence, prevalence, mortality, and coverage of antiretroviral therapy (ART) for 1980-2017 and forecast these estimates to 2030 for 195 countries and territories.
319 citations
TL;DR: This comprehensive assessment of the burden of influenza LRTIs shows the substantial annual effect of influenza on global health, and preparedness planning for potential pandemics should not be overlooked, and vaccine use should be considered.
301 citations
TL;DR: The first global, high-resolution map of P falciparum malaria mortality and the first global prevalence and incidence maps since 2010 are presented and illustrated the rapid decline in burden between 2005 and 2017.
276 citations
TL;DR: These results support global monitoring systems and can inform the optimisation of diagnosis and treatment where P vivax has most impact, and form the malaria estimates for the Global Burden of Disease 2017 study.
259 citations
TL;DR: The state-specific findings in this report indicate the effort needed in each state, which will be useful in tracking and motivating further progress, and similar subnational analyses might be useful for other low-income and middle-income countries.
186 citations
Royal Children's Hospital1, Burnet Institute2, Monash University3, Institute for Health Metrics and Evaluation4, University of Washington5, University of Adelaide6, University of Melbourne7, Johns Hopkins University8, UNICEF9, Columbia University10, Norwegian Institute of Public Health11, Ghent University12, Aga Khan University13, UCL Institute of Child Health14
TL;DR: Country-level estimates of 12 headline indicators from the Lancet Commission on adolescent health and wellbeing, from 1990 to 2016 are presented, suggesting that gender inequity remains a powerful driver of poor adolescent health in many countries.
177 citations
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk-outcome associations as discussed by the authors.
111 citations
TL;DR: Despite substantial progress in Africa, marked national and subnational inequalities in DPT coverage persist throughout the continent, and these results can help identify areas of low coverage and vaccine delivery system vulnerabilities and can ultimately support more precise targeting of resources.
95 citations
TL;DR: A fine-scale geospatial analysis of EBF prevalence and trends in 49 African countries from 2000–2017 is presented, providing policy-relevant administrative- and national-level estimates and the ability to visualize subnational EBF variability and identify populations in need of additional breastfeeding support.
Abstract: Exclusive breastfeeding (EBF)-giving infants only breast-milk (and medications, oral rehydration salts and vitamins as needed) with no additional food or drink for their first six months of life-is one of the most effective strategies for preventing child mortality1-4. Despite these advantages, only 37% of infants under 6 months of age in Africa were exclusively breastfed in 20175, and the practice of EBF varies by population. Here, we present a fine-scale geospatial analysis of EBF prevalence and trends in 49 African countries from 2000-2017, providing policy-relevant administrative- and national-level estimates. Previous national-level analyses found that most countries will not meet the World Health Organization's Global Nutrition Target of 50% EBF prevalence by 20256. Our analyses show that even fewer will achieve this ambition in all subnational areas. Our estimates provide the ability to visualize subnational EBF variability and identify populations in need of additional breastfeeding support.
TL;DR: The successful implementation of the MRC in spite of numerous contextual and operational challenges demonstrated the adaptive capacity of the national immunization programme and its partners that has positive implications for future introductions of Gavi-supported vaccines.
Abstract: Gavi, the Vaccine Alliance, supported a mass vaccination Measles-Rubella Campaign (MRC) in Bangladesh during January–February 2014 We conducted a mixed-method process evaluation to understand the successes and challenges in implementation of the MRC We reviewed documents for the MRC and the immunization programme in Bangladesh; observed meetings, vaccination sessions, and health facilities; and conducted 58 key informant interviews, 574 exit interviews with caregivers and 156 brief surveys with stakeholders involved in immunization Our theory of Change for vaccination delivery guided our assessment of ideal implementation milestones and indicators to compare with the actual implementation processes We identified challenges relating to country-wide political unrest, administrative and budgetary delays, shortage of transportation, problems in registration of target populations, and fears about safety of the vaccine Despite these issues, a number of elements contributed to the successful launch of the MRC These included: the comprehensive design of the campaign; strong partnerships between immunization authorities in the government system, Alliance partners, and civil society actors; and motivated and skilled health workers at different levels of the health system The successful implementation of the MRC in spite of numerous contextual and operational challenges demonstrated the adaptive capacity of the national immunization programme and its partners that has positive implications for future introductions of Gavi-supported vaccines